BD Begins Clinical Trial for GalaFLEX LITE Scaffold in Breast Revision Surgery
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
The botulinum toxin product from Hugel expands its global reach with training and launch events.